Panacea Biotec Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Panacea Biotec Ltd. on BSE

Search Inside the pdf :

Panacea Biotec Ltd.

29 Jul 2025, 05:43PM

412.30

-2.91%

Company Update

Panacea Biotec Ltd - 531349 - Intimation Under Regulation 30 And Regulation 31A(8) Of The Securities …

BSE India

We are pleased to inform that the Company has received on July 29, 2025, the requisite approval from BSE and NSE for reclassification from "Promoter and Promoters'' Group" category to the "Public" category of shareholders of the Company, in accordance with provisions of Regulation 31A(3) of the SEBI (LODR) Regulations, 2015.

pdf

Panacea Biotec Ltd.

19 Jul 2025

412.30

-2.91%

Company Update

Panacea Biotec Ltd - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find enclosed herewith newspaper copies regarding Notice intimating the shareholders about the opening of a Special Window for Re-lodgement of transfer requests of physical shares, in accordance with SEBI Circular No. SEBI/HO/MIRSD-PoD/P/CIR/2025/97 dated July 02, 2025, published on July 19, 2025.

pdf

Panacea Biotec Ltd.

11 Jul 2025

412.30

-2.91%

Company Update

Panacea Biotec Ltd - 531349 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

In connection with our earlier letter dated August 20, 2024, please find attached Demand Order dated 10.07.2025 from the office of the Assistant Commissioner of State tax, GST Bhawan, Mazgon, Mumbai.

pdf

Panacea Biotec Ltd.

09 Jul 2025

412.30

-2.91%

Company Update

Panacea Biotec Ltd - 531349 - Intimation Of Settlement Of Disputes With Apotex Inc., Canada Under …

BSE India

We are pleased to inform you that the parties have executed a Settlement Agreement on July 09, 2025, recording full and final settlement of the disputes forming part of the arbitration among Apotex Inc., the Company and its wholly owned subsidiary, Panacea Biotec Pharma Ltd.

pdf

Panacea Biotec Ltd.

07 Jul 2025

412.30

-2.91%

Company Update

Panacea Biotec Ltd - 531349 - Details Of Shares Dematerialised During June 2025 Under Regulation 74(5) …

BSE India

We would like to inform you that no share has been dematerialised during the month of June, 2025. A copy of the certificate from the Company''s RTA viz. Skyline Financial Services Pvt. Ltd. regarding shares dematerialised as on June 30, 2025, is enclosed herewith.

pdf

Panacea Biotec Ltd.

07 Jul 2025

412.30

-2.91%

Company Update

Panacea Biotec Ltd - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

We are enclosing a certificate dated July 02, 2025, issued by Skyline Financial Services Private Limited, Registrar and Transfer Agent of the Company, confirming compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2025.

pdf

Panacea Biotec Ltd.

26 Jun 2025

412.30

-2.91%

SAST

Panacea Biotec Ltd - 531349 - Closure of Trading Window

BSE India

We would like to inform that the trading window of the Company shall remain closed for all the Designated Persons (including their immediate relatives) of the Company from July 01, 2025 till completion of 48 hours from the announcement of the Unaudited financial results of the Company for the quarter ending June 30, 2025, to the Stock Exchanges.

pdf

Panacea Biotec Ltd.

06 Jun 2025

412.30

-2.91%

Company Update

Panacea Biotec Ltd - 531349 - Details Of Shares Dematerialised During May, 2025 Under Regulation 74(5) …

BSE India

We are enclosing herewith the details of shares dematerialised during the month of May, 2025. A copy of the certificate obtained from RTA in this regard is also attached herewith.

pdf

Panacea Biotec Ltd.

03 Jun 2025

412.30

-2.91%

Company Update

Panacea Biotec Ltd - 531349 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Please find attached Press Release regarding inclusion of EmulsiPan adjuvant in the CEPI Adjuvant Library and its foray into commercialisation of its indigenously developed adjuvants

pdf

Panacea Biotec Ltd.

31 May 2025

412.30

-2.91%

Company Update

Panacea Biotec Ltd - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find attached newspaper copies of the Extract of Statement of Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2025.

pdf

Is Panacea Biotec Ltd. worth buying?

220 Votes:

Buy 77.27%

Sell 13.18%

Hold 9.55%